Additionally, Purdue Pharma will pay the state additional $72.5 million, of which $12.5 million will be available to cities and counties to stop the effects of opioid epidemic.
Furthermore, the pharmaceutical company agreed not to promote opioids in Oklahoma. The settlement resolves all the state’s allegations against Purdue Pharma.
Moreover, the Sackler Family, which is not a defendant in the case, pledged to donate $75 million over five years to the National Center for Addiction Studies and Treatment.
Purdue Pharma is committed to helping those suffering from opioid addiction
In a statement, Purdue Pharma President and CEO Craig Landau, MD., said, Purdue is very pleased to have reached an agreement with Oklahoma that will help those who are battling addiction now and in the future…”
“We see this agreement with Oklahoma as an extension of our commitment to help drive solutions to the opioid addiction crisis, and we pledge Purdue’s ongoing support to the National Center and the life-saving work it will do for generations to come,” he added.
